Join our webinar on April 23rd at 4:00 PM to see how Ashvattha Therapeutics has discovered a way to deliver therapeutics to activated cells without impacting the healthy ones by using systemic treatments for inflammatory diseases. https://hubs.la/Q02sQXHz0
Charlotte Morello’s Post
More Relevant Posts
-
Join our webinar on April 23rd at 4:00 PM to see how Ashvattha Therapeutics has discovered a way to deliver therapeutics to activated cells without impacting the healthy ones by using systemic treatments for inflammatory diseases. https://hubs.la/Q02sQSpr0
-
-
Join our webinar tomorrow at 4:00 PM to see how Ashvattha Therapeutics has discovered a way to deliver therapeutics to activated cells without impacting the healthy ones by using systemic treatments for inflammatory diseases. https://hubs.la/Q02sQTyc0
-
-
Join our webinar tomorrow at 4:00 PM to see how Ashvattha Therapeutics has discovered a way to deliver therapeutics to activated cells without impacting the healthy ones by using systemic treatments for inflammatory diseases. https://hubs.la/Q02sQXKm0
-
-
Join our webinar tomorrow at 4:00 PM to see how Ashvattha Therapeutics has discovered a way to deliver therapeutics to activated cells without impacting the healthy ones by using systemic treatments for inflammatory diseases. https://hubs.la/Q02sQSW40
-
-
Join our webinar tomorrow at 4:00 PM to see how Ashvattha Therapeutics has discovered a way to deliver therapeutics to activated cells without impacting the healthy ones by using systemic treatments for inflammatory diseases. https://hubs.la/Q02sQN810
-
-
New data support CAR-T therapy in neuroinflammatory diseases Kyverna Therapeutics has revealed continued positive results for its CAR-T therapy KYV-101 in B cell-driven autoimmune diseases. https://lnkd.in/eBsxGUQN #CellTherapy #DrugDiscovery #NeuroinflammatoryDiseases
-
-
Discovery Life Sciences has a robust #biorepository of #biospecimens available from #autoimmunedisease patients available for immediate shipment to your facility. PBMCs, plasma, serum and FFPE are all available. Send me a DM if you need an inventory report! #PBMCs #FFPE #tissues #rheumatoidarthritis #SLE #lupus #psoriasis #autoimmune #researchanddevelopment #clinicalsamples
Access to a reliable source of diverse patient samples is crucial for studying autoimmune diseases, allowing for faster identification of unique disease patterns and the development of effective therapeutics and diagnostics. Discovery specializes in prospective biospecimen collections and partners with nearly 200 clinical sites globally to provide a diverse range of autoimmune disease patient samples, including SLE, Crohn’s, rheumatoid arthritis, ulcerative colitis, sickle cell anemia, and more. Let us help move your autoimmune disease research forward. Discuss your project with us today: https://lnkd.in/gvV4TREc #autoimmune #biospecimens
-
-
Check out the most recent article from our partner, Amicus Therapeutics ! Explore Fabry disease's complexities and dive into its depths. Read the article here: https://lnkd.in/g4HRuanr
-
June is #AlzheimersandBrainAwarenessMonth, an important time to raise awareness of the significance of #brainhealth. At Delix Therapeutics, we're developing first-in-class #neuroplastogens that promote the brain's innate ability to repair itself, and in doing so, pioneering a new era in #CNS disease treatment. Learn more about our science here: https://lnkd.in/eCRnJMv5.
-
-
#GeographicAtrophy (GA) is an advanced, vision-threatening form of age-related macular degeneration (AMD) affecting approximately five million individuals worldwide. While there are currently no approved therapeutics for treatment, our #JNJRetina team continues to work to develop innovative solutions for those living with GA. Learn more about our commitment to helping patients with blinding retinal diseases restore and preserve their vision: https://bit.ly/4aO7ZaJ